Your criticism of the company is only partly accurate… I understand that you and Chuck and other investors lost money with Chris Nelson and Kevin Bolin at the helm. Did they intentionally try to make the company fail? I doubt it.
What you don’t seem to have noticed is that both Bolin and Nelson are no longer with the company. Bolin was never a part of the reorganized company and Chris Nelson stayed on for just a year or so after the company was acquired by new management.
QSAM is a completely different entity than it has been before. Have you checked out their web page?
https://qsambio.com/#about
Check out the projects and potential they have:
https://ir.qsambio.com/
Have you read the bios of the folks involved?
https://ir.qsambio.com/company-information/management-team
These guys have successfully done this before. Have they reversed the previous shareholders to minimal levels? Sure. Did that affect me? Obviously. But that has undoubtedly affected Bolin and Nelson as well. You’ll probably enjoy knowing that at least a little.
My perspective might be simplistic, but the future success of the company is another matter. As an entity it is now making decisions that will hopefully allow those involved to bring a new drug to market AND hopefully provide a sizable return to those who have funded the venture…. the venture capitalists.
Proof of this, management‘s recent decision to walk away from a poorly structured VC offer. They didn’t like the terms even though it would have allowed them to uplist to NASDAQ. From what I can gather, they expect good outcomes from their drug trials and they will then be in a stronger negotiating position.
At this point, the only way for the investing public to participate in QSAM’s potential future success is to purchase shares in the open market… or possibly participate in some future share offering of it becomes available to the public.
Watch for opportunities with those you trust.
Recent QSAM News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/20/2024 10:19:46 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:51:43 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/20/2024 11:09:38 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/16/2024 02:51:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 02:56:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 10:08:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:43:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:51:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 08:00:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:30:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 10:14:22 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM